Fear of cancer recurrence: A systematic literature review of self-report measures

Psycho-Oncology

Volumn 21, Issue 6, 2012, Pages 571-587

  Thewes, Belinda ^a   Butow, Phillis ^a   Zachariae, Robert ^b   Christensen, Soren ^b   Simard, Sébastien ^c   Gotay, Carolyn ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

cancer; fear of recurrence; oncology; questionnaires; self report measures

Indexed keywords

BIBLIOGRAPHIC DATABASE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVOR; CINAHL; CLINICAL ASSESSMENT TOOL; CRITICALLY ILL PATIENT; EVIDENCE BASED MEDICINE; FEAR; FEAR OF CANCER RECURRENCE; HUMAN; INTERNAL VALIDITY; INTRARATER RELIABILITY; MEDLINE; NEOPLASM; OUTCOME ASSESSMENT; PSYCHOMETRY; PSYCINFO; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; SCREENING TEST; SELF REPORT; SHORT FORM 36; SYSTEMATIC REVIEW; UNCERTAINTY;

ANXIETY; FEAR; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SURVIVORS;

EID: 84861807284     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.2070     Document Type: Review

References (85)

1. Baker F, Denniston M, Smith, T, West M,. Adult cancer survivors: how are they faring? Cancer 2005; 104 (11 Suppl): 2565-2576.
2. Armes J, Crowe M, Colbourne L, et al,. Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 2009; 27 (36): 6172-6179.
3. Hodgkinson K, Butow P, Hunt G, et al,. The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: the CaSUN (Cancer Survivors' Unmet Needs measure). Psycho-Oncology 2007; 16 (9): 796-804.
4. Hodgkinson K, Butow P, Hunt GE, et al,. Breast cancer survivors' supportive care needs 2-10 years after diagnosis. Support Care Cancer 2007; 15 (5): 515-523. Epub 2006 Nov 21.
5. Sanson-Fisher R, Girgis A, Boyes A, et al,. The unmet supportive care needs of patients with cancer. Cancer 2000; 88 (1): 226-238.
6. Humphris GM, Ozackinci G,. The AFTER intervention: a structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. Br J Health Psychol 2008; 13 (2): 223-230.
7. Vickberg SMJ,. The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med 2003; 25 (1): 16-24.
8. Hodges L, Humphris G,. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psycho-Oncology 2009; 18 (8): 841-848.
9. Northouse LL,. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs 1981; 4 (3): 213-220.
10. LLewellyn C, Weinman J, McGurk M, Humphris GM,. Can we predict which head and neck cancer survivors develop fears of cancer recurrence? J Psychosom Res 2008; 65: 525-532.
11. Kiebert GM, Welvaart K, Kievit J, Psychological effects of routine follow up on cancer patients after surgery. Eur J Surg 1993; 159 (11-12): 601-607.
12. Curran D, van Dongen JP, Aaronson NK, et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). Eur J Cancer 1998; 34 (3): 307-314.
13. Avery A, Lelak T, Solomon N, et al,. Quality of Medical Care Assessment Using Outcome Measures: Eight Disease-specific Applications. Rand: Santa Monica, 1976.
14. Avis NE, Smith KW, McGraw S, et al,. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res 2005; 14 (4): 1007-1023.
15. Melia M, Moy CS, Reynolds SM, et al,. Development and validation of disease-specific measures for choroidal melanoma: COMS-QOLS report no. 2. Arch Ophthalmol 2003; 121 (7): 1010-1020.
16. Zigmond A, Snaith R,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67 (6): 361-370.
17. Roth AJ, Rosenfeld B, Kornblith AB, et al,. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer 2003; 97 (11): 2910-2918.
18. Roth A, Nelson CJ, Rosenfeld B, et al,. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 2006; 47 (4): 340-347.
19. Greenberg DB, Kornblith AB, Herndon JE, et al,. Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress. Cancer 1997; 80 (10): 1936-1944.
20. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology v1.2007. 2007.
21. Esper P, Mo F, Chodak G, et al,. Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate (FACT-P) instrument. Urology 1997; 50: 920-928.
22. Zhao L, Portier K, Stein K, Baker F, Smith T,. Exploratory factor analysis of the Cancer Problems in Living Scale: a report from the American Cancer Society's Studies of Cancer Survivors. J Pain Symptom Manage 2009; 37 (4): 676-686.
23. Baker F, Denniston M, Zabora J, Marcellus D,. Cancer problems in living and quality of life after bone marrow transplantation. J Clin Psychol Med Settings 2003; 10 (1): 27-34.
24. McNair D, Lorr M, Droppleman L,. Manual for the Profile of Mood States. EIT Service: San Diego, California, 1971.
25. de Haes J, van Knippenberg F, Neijt JBJC,. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62 (6): 1034-1038.
26. Easterling DV, Leventhal H,. Contributions of concrete cognition to emotion: neutral symptoms as elicitors of worry about cancer. J Appl Psychol 1989; 74 (5): 787-796.
27. Cameron L, Leventhal H, Love RR,. Trait anxiety, symptom perceptions and illness-related responses among women with breast cancer in remission during a tamoxifen clinical trial. Health Psychol 1998; 17 (5): 459-469.
28. Zuckerman M, Lubin B,. Manual for the Multiple Affect Adjective Check List. EIT Service: San Diego, California, 1965.
29. Lasry J, Margolese R,. Fear of recurrence, breast-conserving surgery, and the trade-off hypothesis. Cancer 1992; 69 (8): 2111-2115.
30. Burstein H, Gelber S, Guadognoli E, Weeks J,. The use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999; 340 (22): 1733-1739.
31. Partridge AH, Gelber S, Peppercorn J, et al,. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004; 22 (20): 4174-4183.
32. Hill J, Kornblith A, Jones D, et al,. A comparative study of the long-term psychosocial functioning of childhood acute leukemia survivors treated by intrathecal methotrexate with and without cranial radiation. Cancer 1998; 82: 208-218.
33. Mirabeau-Beale K, Kornblith A, Penson R, et al,. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol 2009; 114 (2): 353-359.
34. Derogatis L, Spencer P,. The Brief Symptom Inventory: administration, scoring and procedures manual-1. CP Research: Baltimore, 1982.
35. Derogatis L,. Derogatis Sexual Functioning Inventory (DSFI): Preliminary Scoring Manual. CP Research: Baltimore: 1975.
36. Derogatis L,. The Psychosocial Adjustment to Illness Scale (PAIS). J Psychosom Res 1986; 30: 77-91.
37. Mehta SS, Lubeck DP, Pasta DJ, Litwin MS,. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol 2003; 170 (5): 1931-1933.
38. Rabin C, Leventhal H, Goodin S,. Conceptualization of disease timeline predicts posttreatment distress in breast cancer patients. Health Psychol 2004; 23 (4): 407-412.
39. Lerman C, Daly M, Masny A, Balshem A,. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994; 12 (4): 843-850.
40. Deimling G, Wagner L, Bowman K, et al,. Coping among older-adult, long-term cancer survivors. Psychooncology 2006; 15 (2): 143-159.
41. Gotay CC, Pagano IS,. Assessment of Survivor Concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes 2007; 5 (15) DOI: 10.1186/1477-7525-5-15.
42. Radloff L,. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psych Meas 1977; 1 (3): 385-401.
43. Cameron LD, Booth R, Schlatter M, Ziginskas D, Harman J,. Changes in emotion regulation and psychological adjustment following use of a group psychosocial support program for women recently diagnosed with breast cancer. Psycho-Oncology 2007; 16: 171-180.
44. Cameron LD, Diefenbach M,. Vulnerability perceptions and responses to information about genetic testing for breast cancer. 14th World Congress of Psychosomatic Medicine, Cairns, Australia, 1997.
45. Diefenbach M, Mohamed N, Horwitz E, Pollack A,. Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of age. Psychol Health Med 2008; 13 (2): 146-161.
46. Diefenbach MA, Miller S, Daly M,. Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychol 1999; 18 (5): 532-536.
47. Diefenbach M, Hamrick N, Uzzo R, et al,. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. J Urol 2003; 170: 166-169.
48. Franssen S, Lagarde S, van Werven J, et al,. Psychological factors and preferences for communicating prognosis in esophageal cancer patients. Psycho-Oncology 2009; 18 (11): 1199-1207.
49. Bartelink H, van Dam FJ,. Psychological effects of breast conserving therapy in comparison with radical mastectomy. Int J Radiat Oncol Biol Physiol 1985; 11: 381-385.
50. de Haes J, van Oostrom MKW,. The effect of radical and conserving surgery on the quality of life of early breast cancer patients. Eur J Surg Oncol 1986; 12: 337-342.
51. Hilton BA, The relationship of uncertainty, control, commitment, and threat of recurrence to coping strategies used by women diagnosed with breast cancer. J Behav Med 1989; 12 (1): 39-54.
52. Mellon S, Kershaw T, Northouse LL, Freeman-Gibb L, A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psycho-Oncology 2007; 16: 214-223.
53. Walker BL, Adjustment of husbands and wives to breast cancer. Cancer Pract 1997; 5 (2): 92-98.
54. Stanton AL, Danoff-Burg S, Huggins ME,. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psycho-Oncology 2002; 11 (2): 93-102.
55. Lazarus R, Folkman S,. Stress, Appraisal and Coping. Springer Publishing: New York, 1984.
56. van den Beuken-van Everdingen M, Peters M, de Rijke J, et al,. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psycho-Oncology 2008; 17 (11): 1137-1145.
57. Horowitz MJ, Wilner N, Alvarez W,. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979; 41: 209-218.
58. Veit C, Ware J, The structure of psychological distress and well-being in general populations. Clin Psychol 1983; 51: 730-742.
59. Herschbach P, Berg P, Dankert A, et al,. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res 2005; 58 (6): 505-511.
60. Dankert A, Duran G, Engst-Hastreiter U, et al,. Progredienzangst bei Patienten mit Tumorerkrankungen. Diabetes mellitus und entzundlich-rheumatischen Erkrankungen. Rehabilitation (Stuttgart) 2003; 42 (3): 155-163.
61. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (4th edn). AP Association: Washington, DC, 1994.
62. Derogatis L,. Symptom Checklist-90 (SCL90-R): Administration, Scoring, and Procedures Manual NCS: Minneapolis, 1994.
63. Ware J, Kosinski M, Keller S,. A 12-item short-form health survey: construction of scales and preliminary test of reliability and validity. Med Care 1996; 34: 220-226.
64. Herschbach P, Berg P, Waadt S, et al,. Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom 2010; 79 (1): 31-38.
65. Herschbach P, Book K, Dinkel A, et al,. Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer 2010; 18 (4): 471-479.
66. Shim E, Shin Y, Oh D, Hahm B,. Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry 2010; 32: 169-175.
67. Mehnert A, Herschbach P, Berg P, Henrich G, Koch U,. Fear of progression in breast cancer patients-validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF). Z Psychosom Med Psyc 2006; 52 (3): 274-288.
68. Mehnert A, Berg P, Henrich G, Herschbach P,. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psycho-Oncology 2009; 18: 1273-1280.
69. Simard S, Savard J,. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 2009; 17 (3): 241-251.
70. Lee-Jones C, Humphries G, Dixon R, Hatcher M,. Fear of cancer recurrence-a literature review and proposed cognitive formulation to explain the exacerbation of fears. Psycho-Oncology 1997; 6: 95-105.
71. Robbins J, Kirmayer L,. Transient and persistent hypochondrical worry in primary care. Psychol Med 1996; 26: 575-589.
72. Simard S, Savard J,. Screening and psychiatric comorbidity of clinical fear of cancer recurrence. 4th Canadian Breast Cancer Research Alliance Reasons for Hope Scientific Conference, Vancouver, Canada, 2008.
73. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11: 193-205.
74. Lipscomb J, Gotay C, Snyder C,. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 2007; 57: 278-300.
75. Thomas S, Glynne-Jones R, Chait I, Marks D,. Anxiety in long-term cancer survivors influences of acceptability of planned discharge from follow-up. Psycho-Oncology 1997; 6 (3): 190-199.
76. Kirschner B, Guyatt G,. A methodological framework for assessing health indices. J Chron Dis 1985; 38 (1): 27-33.
77. Gotay C, Lipscomb J, Snyder CF,. Reflections on findings of the Cancer Outcomes Measurement Working Group: moving to the next phase. J Natl Cancer Inst Monogr 2005; 97: 1568-1574.
78. Reise S,. Item response theory and its applications for cancer outcomes measurement. In Outcomes Assessment in Cancer, Lipscomb J, Gotay C, Snyder C, (eds). Cambridge University Press: Cambridge, 2005; 425-444.
79. Kornblith AB, Powell M, Regan MM, et al,. Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psycho-Oncology 2007; 16 (10): 895-903.
80. Schover L, Yetman R, Tauason L, et al,. Partial mastectomy and breast reconstruction. A comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer 1995; 75 (1): 54-64.
81. Noguchi M, Kitagawa H, et al,. Psychologic and cosmetic self-assessments of breast conserving therapy compared with mastectomy and immediate breast reconstruction. J Surg Oncol 1993; 54: 260-266.
82. Campbell BH, Marbella A, Layde PM,. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope 2000; 110 (6): 895-906.
83. Janni W, Rjosk D, Dimpfl TH, et al,. Quality of life influenced by primary surgical treatment for stage I-III breast cancer-long-term follow-up of a matched-pair analysis. Ann Surg Oncol 2001; 8 (6): 542-548.
84. Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I,. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care 2007; 16 (2): 144-149.
85. Skaali T, Fossa SD, Bremnes R, et al,. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology 2009; 18: 580-588.